Primera Therapeutics

Private

Rockville, MarylandHealthcare & Life Scienceshttps://primeratherapeutics.com/

Last Round

Accelerator

Dec 29, 2022

Company Overview

Primera Therapeutics is a biotechnology company that develops gene editing therapies to treat mitochondrial diseases by targeting inherited mutant mitochondrial DNA.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapymitochondrial gene editingrare disease therapeuticsTALE-based editingprecision medicinedrug discoverybiotechmtDNA editingclinical stage biotechgenetic medicinetherapeutic pipelinegenomic medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Primera Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Primera Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Primera Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Dec 29, 2022

View all Funding Rounds

Primera Therapeutics Investors

Notable investors and investment history

Primera Therapeutics investors
Investor	Rounds
Hibiscus BioVentures	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 29, 2022
Raised an accelerator round with Hibiscus BioVentures, Cellectis, and Mayo Clinic.

View all signals

Primera Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Primera Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Primera Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersRockville, Maryland

Employee Range3

Year Founded2022

Last FundingDec 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.